Continuation versus discontinuation of intravenous oxytocin in the active phase of labour

Sidsel Boie; Niels Uldbjerg; Pinar Bor; Jim G Thornton; Irene M de Graaf; Camille Le Ray; Julie Glavind; François Goffinet; Aude Girault

doi:10.1002/14651858.CD015995

Continuation versus discontinuation of intravenous oxytocin in the active phase of labour

Cochrane Database Syst Rev. 2024 Nov 29;11(11):CD015995. doi: 10.1002/14651858.CD015995.

Authors

Sidsel Boie^{1

2}, Niels Uldbjerg^{2

3}, Pinar Bor^{2

3}, Jim G Thornton⁴, Irene M de Graaf⁵, Camille Le Ray⁶, Julie Glavind^{2

3}, François Goffinet⁶, Aude Girault⁶

Affiliations

¹ Department of Obstetrics and Gynecology, Regional Hospital of Randers, Randers, Denmark.
² Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
³ Department of Obstetrics and Gynecology, Aarhus University Hospital, Aarhus N, Denmark.
⁴ Division of Child Health, Obstetrics and Gynaecology, School of Medicine, University of Nottingham, Nottingham, UK.
⁵ Department of Obstetrics and Gynaecology, Amsterdam University Medical Centers, Amsterdam, Netherlands.
⁶ Port Royal Maternity Hospital, Assistance Publique des Hôpitaux de Paris - Université Paris Cité, Paris, France.

Abstract

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the effects of discontinuing intravenous oxytocin stimulation in pregnant women during the active phase of induced or augmented labour.

MeSH terms

Administration, Intravenous
Female
Humans
Labor, Induced* / methods
Labor, Obstetric / drug effects
Oxytocics* / administration & dosage
Oxytocin* / administration & dosage
Pregnancy
Randomized Controlled Trials as Topic
Systematic Reviews as Topic

Substances

Oxytocin
Oxytocics